Skip to main content
Professional Technical IVT

myelofibrosis

A myeloproliferative neoplasm characterized by bone marrow fibrosis, extramedullary hematopoiesis, and progressive bone marrow failure.

Full Definition

Myelofibrosis is a clonal hematopoietic stem cell disorder classified as a myeloproliferative neoplasm. The disease is characterized by progressive bone marrow fibrosis, which leads to cytopenias and compensatory extramedullary hematopoiesis, typically manifesting as splenomegaly and hepatomegaly. Myelofibrosis can occur as a primary disorder (primary myelofibrosis) or secondary to other myeloproliferative neoplasms such as polycythemia vera or essential thrombocythemia. The disease is associated with constitutional symptoms and has a variable prognosis. Allogeneic stem cell transplantation remains the only curative therapy, while JAK inhibitors can provide symptomatic relief.

Usage

Usage note: Specify 'primary' or 'secondary' myelofibrosis when the distinction is clinically relevant.

In Context

  • "The patient's progressive anemia and massive splenomegaly were consistent with myelofibrosis." — clinical assessment
  • "Bone marrow biopsy showed grade 3 fibrosis confirming the diagnosis of myelofibrosis." — pathology report

Also known as

primary myelofibrosis agnogenic myeloid metaplasia

Contrasted with

polycythemia vera essential thrombocythemia

Don't confuse with

myelodysplastic syndrome aplastic anemia

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON